Heard on the Street: Heart disease remains humanity’s top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make money

Heart disease remains humanity’s top killer, yet for drugmakers and Wall Street, it is becoming one…

Might I be a candidate for a bit of T-maxxing? 

Driven by internet trends and fatigue, I decided to test my testosterone levels—only to uncover the…

Want to lower your risk of dementia? It doesn’t involve a blood test

New blood tests are helping doctors diagnose whether Alzheimer’s or something else is causing a patient’s…

Ipsen Weighs U.S. Manufacturing Investment

The French drugmaker is considering building a U.S. production site, joining other European companies looking across…

Here’s how to understand Oura ring sleep scores. Read more in this week’s WSJ Wellness newsletter.

People are going to great lengths to optimize their sleep. Plus, the boomers living with their…

The double-cleanse shower, fans say, promises to clean skin while also nourishing it—and making you smell better, too.

Why washing your body once may no longer be good enough

The Relentless Crypto Billionaire Who Moved to Venezuela in Pursuit of Oil

Fred Ehrsam, a Trump administration ally and co-founder of Coinbase, lived for months in a luxury…

The Relentless Crypto Billionaire Who Moved to Venezuela in Pursuit of Oil

Fred Ehrsam, a Trump administration ally and co-founder of Coinbase, lived for months in a luxury…

A new report shows 90% of major brand-name biologic drugs losing exclusivity over the next decade have no low-cost competitors in development

A new industry report shows 90% of major brand-name biologic drugs losing exclusivity over the next…

Chinese biotech companies are training their sights on one of the most lucrative medicines: GLP-1s

Long a maker of low-end generic drugs, the country is now home to biotech firms that…